View Recording
PowerPoint
Upcoming Grail Events: 11/7/24 & 12/11/24
Additional publication resources:
https://grail.com/manuscripts/
1. Validation for current Galleri assay: Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set (All of our sensitivity, specificity test performance metrics are from this study)
2. Implementation study: Blood-based tests for multi cancer early detection (PATHFINDER): a prospective cohort study (Our 43% positive predictive value comes from this study)
3. Case series publication (Three stage 1 diagnoses): A multi-cancer early detection blood test using machine learning detects early-stage cancers lacking USPSTF-recommended screening.